BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheele J, Schmidt SA, Tenzer S, Henne-Bruns D, Kornmann M. Overstaging: A Challenge in Rectal Cancer Treatment. Visc Med 2018;34:301-6. [PMID: 30345289 DOI: 10.1159/000488652] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Reginelli A, Clemente A, Sangiovanni A, Nardone V, Selvaggi F, Sciaudone G, Ciardiello F, Martinelli E, Grassi R, Cappabianca S. Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality Approach. J Clin Med 2021;10:641. [PMID: 33567516 DOI: 10.3390/jcm10040641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hüttner FJ, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Debus J, Jäger D, Diener MK. Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis. J Natl Cancer Inst 2019;111:887-902. [PMID: 31077329 DOI: 10.1093/jnci/djz081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Giesen LJX, Borstlap WAA, Bemelman WA, Tanis PJ, Verhoef C, Olthof PB; DUTCH SNAPSHOT RESEARCH GROUP. Effect of understaging on local recurrence of rectal cancer. J Surg Oncol 2020;122:1179-86. [PMID: 32654177 DOI: 10.1002/jso.26111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Han C, Tang X, Yang M, Zhang K, Liu J, Lin R, Ding Z. How Useful Is Endoscopic Ultrasound in Differentiating T3/T4a T Stage of Colorectal Cancer: A Prospective Study. Front Oncol 2022;11:618512. [DOI: 10.3389/fonc.2021.618512] [Reference Citation Analysis]
5 Kim JC, Yu CS, Lim SB, Park IJ, Yoon YS, Kim CW, Kim JH, Kim TW. Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort analysis using propensity-score matching. Int J Colorectal Dis 2021. [PMID: 34398263 DOI: 10.1007/s00384-021-04003-8] [Reference Citation Analysis]
6 Fernández-Martos C, Pericay C, Losa F, García-Carbonero R, Layos L, Rodríguez-Salas N, Martin-Richard M, Alonso-Orduña V, Vera R, Gallego J, Capdevila J, Salud A, Nogué M, Maurel J, Guash I, Montagut C, Lopez C, Macias I, Jain RK, Garcia-Albeniz X. Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial. JAMA Oncol 2019;5:1566-73. [PMID: 31465088 DOI: 10.1001/jamaoncol.2019.2294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]